Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shoko Sonobe Shimamura"'
Autor:
Yoshihiro Masui, Takehito Shukuya, Shunichi Kataoka, Hitomi Shiozaki, Kana Kurokawa, Ikuko Nakamura, Taichi Miyawaki, Yoshika Koinuma, Tetsuhiko Asao, Ryota Kanemaru, Shoko Sonobe Shimamura, Tomoyasu Mimori, Yoichiro Mitsuishi, Ken Tajima, Naoko Shimada, Kazuhisa Takahashi
Publikováno v:
Thoracic Cancer, Vol 15, Iss 32, Pp 2291-2297 (2024)
Abstract Objectives This study aimed to investigate the characteristics of patients with recurrent or advanced non‐small cell lung cancer (NSCLC) treated with tyrosine kinase inhibitors (TKIs) or immune‐checkpoint inhibitors (ICIs) who developed
Externí odkaz:
https://doaj.org/article/c859515e911947f1a830ca4533f1af24
Autor:
Koichiro Kanamori, Kentaro Suina, Takehito Shukuya, Fumiyuki Takahashi, Takuo Hayashi, Kieko Hara, Tsuyoshi Saito, Yoichiro Mitsuishi, Shoko Sonobe Shimamura, Wira Winardi, Ken Tajima, Ryo Ko, Tomoyasu Mimori, Tetsuhiko Asao, Masayoshi Itoh, Hideya Kawaji, Yoshiyuki Suehara, Kazuya Takamochi, Kenji Suzuki, Kazuhisa Takahashi
Publikováno v:
Thoracic Cancer, Vol 14, Iss 12, Pp 1089-1097 (2023)
Abstract Background Thymic squamous cell carcinoma and type B3 thymoma are primary neoplasms of the anterior mediastinum that are sometimes difficult to differentiate from one another histologically. However, only a few immunohistochemical markers ar
Externí odkaz:
https://doaj.org/article/68cea7b7cfed4f3e8ae2bc5b691dc2fb
Autor:
Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, Daisuke Hayakawa, Kana Kurokawa, Shiting Xu, Keita Miura, Yoichiro Mitsuishi, Ken Tajima, Rina Shibayama, Naoko Shimada, Fumiyuki Takahashi, Kazuhisa Takahashi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The prognosis of patients with NSCLC harboring oncogenic driver gene alterations, such as EGFR gene mutations or ALK fusion, has improved dramatically with the advent of corresponding molecularly targeted drugs. As patients were f
Externí odkaz:
https://doaj.org/article/a899952e22844f689bb111b8f1dde16a
Autor:
Koichiro Kanamori, Kentaro Suina, Takehito Shukuya, Fumiyuki Takahashi, Takuo Hayashi, Kieko Hara, Tsuyoshi Saito, Yoichiro Mitsuishi, Shoko Sonobe Shimamura, Wira Winardi, Ken Tajima, Ryo Ko, Tomoyasu Mimori, Tetsuhiko Asao, Masayoshi Itoh, Hideya Kawaji, Yoshiyuki Suehara, Kazuya Takamochi, Kenji Suzuki, Kazuhisa Takahashi
Publikováno v:
Thoracic Cancer. 14:1089-1097
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39eb92b87fa2c90c4c74f3b5bda32c35
https://doi.org/10.1111/1759-7714.14853
https://doi.org/10.1111/1759-7714.14853
Autor:
Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, Daisuke Hayakawa, Kana Kurokawa, Shiting Xu, Keita Miura, Yoichiro Mitsuishi, Ken Tajima, Rina Shibayama, Naoko Shimada, Fumiyuki Takahashi, Kazuhisa Takahashi
Publikováno v:
BMC cancer. 22(1)
Background The prognosis of patients with NSCLC harboring oncogenic driver gene alterations, such as EGFR gene mutations or ALK fusion, has improved dramatically with the advent of corresponding molecularly targeted drugs. As patients were followed u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff7ad6e631cb688e803e29564343f44b
https://pubmed.ncbi.nlm.nih.gov/35337281
https://pubmed.ncbi.nlm.nih.gov/35337281